Related Experiment Videos

Ironstrene (ferric sodium edetate) treatment of anaemic infants

Insights

Iron deficiency anaemia is common in 1-year-olds. Sodium iron edetate effectively increased hemoglobin (Hb) levels, but levels decreased after treatment cessation.

Area of Science:

  • Pediatrics
  • Hematology
  • Public Health

Background:

  • Iron deficiency anaemia (IDA) is a significant health concern in young children.
  • Early detection and treatment are crucial for preventing long-term developmental consequences.
  • Understanding hemoglobin (Hb) levels in healthy 1-year-olds is essential for identifying IDA.

Purpose of the Study:

  • To assess Hb levels in healthy 1-year-old children in central Norway.
  • To identify children with IDA (Hb ≤ 10.8 g/100 ml).
  • To evaluate the efficacy of sodium iron edetate in treating IDA and its sustained effect.

Main Methods:

  • Cross-sectional study involving 141 healthy 1-year-olds.
  • Hb levels were measured to diagnose IDA.
  • Children diagnosed with IDA were treated with sodium iron edetate for 4 weeks.
  • Follow-up measurements were taken immediately after treatment, 4 weeks post-treatment, and 1 year later.

Main Results:

  • 28.4% (40 out of 141) of children had Hb levels ≤ 10.8 g/100 ml.
  • Sodium iron edetate treatment led to a significant increase in Hb levels.
  • Hb levels showed a significant decline after treatment cessation, continuing over 1 year.
  • Hb levels peaked approximately 2 weeks after treatment completion.

Conclusions:

  • A notable prevalence of IDA exists in healthy 1-year-olds in the studied population.
  • Sodium iron edetate is effective in rapidly improving Hb levels in anemic children.
  • The positive effects of sodium iron edetate on Hb levels are not sustained long-term after treatment discontinuation.

Related Concept Videos